Evidence map›Paper›PMID 30615640›Full record

ArticlePloS one2019

Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute.

Kai Januschowski, Sven Schnichels, José Hurst, Christine Hohenadl, Charlotte Reither, Annekatrin Rickmann, Lisa Pohl, Karl-Ulrich Bartz-Schmidt, Martin S Spitzer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Kai JanuschowskiEye Clinic Sulzbach-Saar, Sulzbach-Saar, Germany.ORCID 0000-0001-7061-5930
Sven SchnichelsUniversity Eye Clinic Tübingen, Centre for Ophthalmology, Tübingen, Germany.
José HurstUniversity Eye Clinic Tübingen, Centre for Ophthalmology, Tübingen, Germany.
Christine HohenadlCroma Pharma GmbH, Leobendorf, Austria.
Charlotte ReitherCroma Pharma GmbH, Leobendorf, Austria.
Annekatrin RickmannEye Clinic Sulzbach-Saar, Sulzbach-Saar, Germany.ORCID 0000-0003-1651-5714
Lisa PohlUniversity Eye Clinic Tübingen, Centre for Ophthalmology, Tübingen, Germany.
Karl-Ulrich Bartz-SchmidtUniversity Eye Clinic Tübingen, Centre for Ophthalmology, Tübingen, Germany.
Martin S SpitzerUniversity Eye Clinic Hamburg-Eppendorf, Hamburg, Germany.
STZ eyetrial · DECroma Pharma (Austria) · ATKnappschaftsklinikum Saar · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo characterize the biophysical properties of an artificial vitreous body substitute (VBS), which consists of a biocompatible, cross-linked, hyaluronic acid (HA)-based hydrogel, by analysing the VBS's influence on intraocular pressure (IOP) and retinal integrity in distinct ex vivo eye models in order to evaluate the its potential for in vivo biocompatibility testing.

methodsPig eyes were obtained immediately postmortem, and VBS was injected after core-vitrectomy. IOP was followed for 24 h (n = 5). VBS influence on retinal integrity was investigated using isolated bovine retinas superfused with an oxygen saturated nutrient solution. An electroretinogram (ERG) was recorded on explanted bovine retinae using silver/silver chloride electrodes; after application of VBS for 2 min, a washout period of 70 min was employed. The percentage of a-and b-wave reduction at the end of the washout phase was compared to baseline values (n = 5). Data were calculated throughout as the mean and the standard deviation. qRT-PCR (Bax/Bcl-2-ratio, GFAP- and PGP9.5-levels) or western blot analysis was used to test for toxicity of Princess Volume after 24 h (and β-3 tubulin with GAPDH as a control gene). Significance was estimated by Student´s t-test; p ≤0.05 was considered to be statistically significant.

resultsThe IOP increased non-significantly by 10% after 24 h. Short-term biocompatibility testing using isolated superfused bovine retinas showed neither significant reductions of the b-wave nor the a-wave amplitudes (b-wave reduction 14.2%, p>0.05; a-wave reduction 23.9%, p>0.05). qRT-PCR and western blot analysis did not reveal significant toxicity after 24 h.

conclusionsThe manufactured HA-based hydrogel showed highly favourable biophysical characteristics in the explored ex vivo models, justifying in vivo studies enabling the assessment of biocompatibility.

Indexed as

AnimalsBiocompatible MaterialsBiophysical PhenomenaCattleCross-Linking ReagentsElectroretinographyHyaluronic AcidHydrogelsIntraocular PressureIn Vitro TechniquesMaterials TestingRefractometryRetinaRheologySus scrofaVitrectomyBiocompatible MaterialsCross-Linking ReagentsHyaluronic AcidHydrogels

Identifiers

PMID30615640
PMCPMC6322733
OpenAlexW2910626228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.